Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). - Wikidata - awgldk - TriplyDB

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

http://www.wikidata.org/entity/Q46853511

about

Targeted therapy of gastrointestinal stromal tumours Somatic DNA mutation analysis in targeted therapy of solid tumours Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis Review article: the biology, diagnosis and management of gastrointestinal stromal tumours The GIST of targeted therapy for malignant melanoma Primary gastrointestinal stromal tumors: Current advances in diagnostic biomarkers, prognostic factors and management of its duodenal location Current management and prognostic features for gastrointestinal stromal tumor (GIST)Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients A nomogram to predict disease-free survival after surgical resection of GIST P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases.Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial Targeted therapy for cancer: the gastrointestinal stromal tumor model.NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting.A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region.Practical aspects of risk assessment in gastrointestinal stromal tumors.Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease.Gastrointestinal Stromal Tumors with Unusual Localization: Report of Three Cases with a Brief Literature Review.Transsacral excision with pre-operative imatinib mesylate treatment and approach for gastrointestinal stromal tumors in the rectum: A report of two cases.Updates on the management of gastrointestinal stromal tumors.Adjuvant treatment of GIST: patient selection and treatment strategies.Adjuvant therapy for high-risk gastrointestinal stromal tumour: considerations for optimal management.Clinical and therapeutic considerations of GIST The role of adjuvant and neoadjuvant therapy in gastrointestinal stromal tumors.MDCT features of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumours.Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.Management of resectable gastrointestinal stromal tumor.Gastrointestinal stromal tumor: 15-years' experience in a single center The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting.Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants Epidemiology, survival, and costs of localized gastrointestinal stromal tumors Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal.Efficacy of imatinib mesylate neoadjuvant treatment for a locally advanced rectal gastrointestinal stromal tumor.Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.Towards global consensus in the treatment of gastrointestinal stromal tumor Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: proposal for a macroscopic classification of GIST

P2860

Q26745633-A4A8D615-3C17-4F19-9A13-BAAD222546BD Q26770324-A43A5B3D-2318-419A-A38F-A525602D3D9A Q26782641-C4D7F9FA-EF77-4887-A98E-628F03CCE527 Q26825310-C6C49BBF-6F34-4796-9E82-FCF74394A509 Q26827092-CAE8C1DC-0A8A-41DD-97C9-600315DB8AA6 Q26829970-30CBEBDC-1D1B-4F5C-AA90-D9DB684DA165 Q28391684-530751E8-B3D8-448F-BA6D-12C18AAAB533 Q28765146-9445882E-CBD2-4A5A-9145-B4B75BE2B25F Q30300823-B67A8F52-1C87-405E-870A-D06853552138 Q30366151-4DEE70D4-89DB-4901-B9CE-0E4F5A6B2511 Q33354638-3F6D9CEC-BCE8-4501-BA8A-53EC7C112FED Q33583469-F63D4980-1320-4027-92C1-651D2B1D457B Q33633409-37390CE1-630A-46F8-9A40-837666E10EB5 Q33690657-B6272E68-8A85-4221-8750-8822AA875C50 Q33699901-AFCCD5F7-38F2-43D7-AD78-0EED35BD1C3C Q33807742-10300091-F282-48BB-86EB-9E5E367B8060 Q33921067-ED5AFDB4-2C28-4D24-93AE-87F3EA6C576D Q33962015-57EBB759-07B1-4B3A-9906-82488B0C28D1 Q34005890-DA2463D2-CF13-46D0-BCA7-9B3A1036D3BC Q34021413-AECDB8CD-1265-467F-9198-2F909206BC44 Q34042348-C68C8FEA-7D3D-4A83-B765-473D4AD04C1C Q34089013-8DE180DD-A473-4E85-AE0B-EDE4FFA827CC Q34141467-45CD3AD8-AF23-4987-AFD9-A8735CD47FCA Q34256921-D73CD754-490F-4860-B916-4F402F1884E7 Q34270274-C808F9B1-18F9-4778-9557-F04E64DB949F Q34300784-15C386E3-0DFA-4B3B-AE0A-7CE336711A46 Q34341168-323737E8-DB46-4591-9926-64211D8EAA84 Q34359712-5CF1FF01-D376-4B58-BD4F-B55D71889B19 Q34392125-CC6657D5-50BC-4430-AD9B-34D14ECE23D8 Q34407270-696EE959-BC33-424D-A745-09197D86FFE3 Q34604924-A3E40EF7-B034-435A-9008-0CCF6F0E3D3A Q34623358-12D5ACDE-D3BA-4E5F-ABFA-64453ADC75B2 Q34629408-92B71659-C735-4BE1-AEBE-C6458C6F550A Q34700954-71DE9FA1-6A20-4CC1-BED9-A0496BA9BF08 Q34748180-F61FECA3-D3DD-4642-8C34-19448A284681 Q35026332-4DD9EA05-B164-4FAC-A90B-5A4BA7C0D098 Q35134631-C9BB862F-2510-4D70-A6AF-35511E85862F Q35220032-DB6E66BA-588C-4305-86CE-7D2FAEFAD808 Q35671104-4C536E6C-DEBE-4DAA-966A-97E45BE0EC00 Q35702769-98A17D07-8E28-4DF2-92F7-FB9BA7862FDA

P2860

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

http://www.wikidata.org/entity/Q46853511

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Tumor mitotic rate, size, and ...... testinal stromal tumor (GIST).

@en

Tumor mitotic rate, size, and ...... testinal stromal tumor (GIST).

@nl

type

label

Tumor mitotic rate, size, and ...... testinal stromal tumor (GIST).

@en

Tumor mitotic rate, size, and ...... testinal stromal tumor (GIST).

@nl

prefLabel

Tumor mitotic rate, size, and ...... testinal stromal tumor (GIST).

@en

Tumor mitotic rate, size, and ...... testinal stromal tumor (GIST).

@nl

P1433

Q46853511-EF6A2868-143E-45D9-A821-6EF82875749D

P1476

Q46853511-98016BD3-B92C-4023-9153-CD80E46DA972

P2093

Q46853511-4B3C787B-5541-446C-8F08-6ED46B0B852B

Q46853511-5E158CEF-6D8B-4689-AAAA-40DCA880CEB6

Q46853511-6979A08C-9F54-4257-A861-0B8ECDF92267

Q46853511-864A4824-E999-4A7E-9D8C-9EE12A0D78C5

Q46853511-B115688E-943D-4946-BB38-AA35431864ED

Q46853511-C66CE323-52F2-43B7-8F60-C0976135CBE1

Q46853511-CA507AC4-A034-4506-998A-D9C59DF5ADB8

P2860

Q46853511-70799836-40AA-4993-BF23-F41AEAD07938

Q46853511-85FDF090-D61E-45F6-8946-154208ACFE29

Q46853511-C4A06E61-DA91-4158-9DC5-916E41FF8C46

Q46853511-EBB00F58-3BD7-493A-B51C-DACA6F7DDC65

P304

Q46853511-D5E00D17-7E1C-4A80-9E09-88C97B19AD74

P31

Q46853511-0F11812C-3C4A-4ABF-BB1F-019C82984046

P356

Q46853511-4D181834-C8EF-4FC3-BF58-3ECE2D3D1A15

P407

Q46853511-AADDB318-AF43-4FA1-BD48-CFF83AAF3F49

P433

Q46853511-328B610F-81D0-4ABB-9B9A-670C125D1459

P478

Q46853511-00E76934-7034-4629-938A-32D8BB6A6623

P50

Q46853511-28C039C6-B171-4B35-9C73-104F3AD9C052

Q46853511-B2B58E45-BA7F-4BC0-A1EE-CA6B2CDC6581

Q46853511-B39D0C5C-6502-4BEF-9568-01D2AE8EE30E

P577

Q46853511-B435D7DC-CCAB-440B-885F-DDE192F49C7C

P5875

Q46853511-2237F59F-DE6C-4884-8008-A7D6520DAD82

P698

Q46853511-EB3DEA7F-C6BF-48C3-A410-6631B7E8013A

P356

P1433

P1476

Tumor mitotic rate, size, and ...... testinal stromal tumor (GIST).

@en

P2093

Cristina R Antonescu

http://www.w3.org/2001/XMLSchema#string

Kui Hin Liau

http://www.w3.org/2001/XMLSchema#string

Lisa Saran

http://www.w3.org/2001/XMLSchema#string

Mithat Gönen

http://www.w3.org/2001/XMLSchema#string

Peter Besmer

http://www.w3.org/2001/XMLSchema#string

Robert G Maki

http://www.w3.org/2001/XMLSchema#string

Ronald P Dematteo

http://www.w3.org/2001/XMLSchema#string

P2860

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size.

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

Prognostic value of KIT mutation in gastrointestinal stromal tumors

Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese.

P304

608-615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.23199

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227508341

http://www.w3.org/2001/XMLSchema#string

P698

18076015

http://www.w3.org/2001/XMLSchema#string